Csilla Hasovits

Biography

 Dr Csilla Hasovits completed her medical degree with first class honours at the University of New South Wales in 2004. She undertook post-graduate and specialist training in medical oncology at Royal North Shore Hospital and was awarded her Fellowship with the Royal Australasian College of Physicians in 2012. Csilla has since combined clinical practice in medical oncology, working within a multidisciplinary team environment across a range of cancers, with research in her position as lung cancer research fellow at the Kolling Institute of Medical Research. Dr Hasovits has obtained additional experience in palliative care medicine in both the community and hospital settings. Dr Hasovits has a number of peer-reviewed publications, review articles and book chapters covering a broad spectrum of cancers including lung, gastrointestinal, kidney and gynaecological cancers. She is involved in teaching and the training of medical students, junior doctors and allied health staff. Dr Hasovits regularly participates in lectures and presentations to medical students, GPs, specialists and special interest groups. Her current professional memberships include the Medical Oncology Group of Australia, American Society of Clinical Oncology and a number of Australasian clinical trial groups. Dr Hasovits is actively involved in both clinical and translational research, with a particular interest in thoracic malignancies. She is undertaking a higher research degree through the University of Sydney which is exploring mechanisms of resistance to personalised lung cancer treatments and for which she has received awards from the Cancer Institute and Cancer Council NSW, Royal North Shore Hospital, Kolling Institute of Medical Research and University of Sydney. Csilla has presented her research findings at national and international conferences and published in key international journals. Dr Hasovits is a member of a number of research groups, including the Australian Lung cancer trials group, Australasian Gastrointestinal Trials Group and Australia and New Zealand Urogenital and Prostate Cancer Trials Group.

Research Interest

Lung cancer General oncology Gastrointestinal Cancer Kidney Cancer Gynaecological cancer